| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |